Intas Pharmaceuticals Strengthens Position in Global Biosimilar Market Through UDENYCA Acquisition

Intas Pharmaceuticals acquires UDENYCA from Coherus BioSciences, expanding its FDA-approved biosimilar portfolio and strengthening its presence in the U.S. and international biosimilar landscapes.